课题基金 / 基金详情

Pathobiology of the small leucine rich repeat proteoglycans in cartilage, intervertebral disc and tendon degeneration

Pathobiology of the small leucine rich repeat proteoglycans in cartilage, intervertebral disc and tendon degeneration
软骨、椎间盘和肌腱变性中富含亮氨酸的小重复蛋白聚糖的病理学
批准号:
nhmrc : 352562
负责人:
Dr James Melrose
金额:
$34.45万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

Dr James Melrose的其他基金

相似基金

相关文献

中文摘要
翻译
1993-1994年,背部问题(700 M美元)、骨关节炎(600 M美元)、肌肉和肌腱疾病(500 M美元)占澳大利亚肌肉骨骼(MSK)卫生保健支出的60%,是向全科医生陈述的第二大常见原因,是卫生系统支出(>30亿美元)的第三大贡献者,并导致约30万人入院,约1500万次医疗服务和1300多万张处方。在65岁的人中,约有50%的人因MSK病而严重残疾。澳大利亚人口普查数据显示,随着澳大利亚人口寿命的延长,老龄化趋势将导致MSK疾病的发生率增加,从而给医疗预算带来越来越大的负担。创伤性关节负荷引起的运动或体力活动的极端水平会导致MSK组织中胶原纤维的过度负荷,从而导致其失效和组织功能丧失。胶原纤维破坏的共同终末阶段之前,基质改变可能使MSK组织容易受到酶和机械损伤。其中一个变化是富含亮氨酸的小分子蛋白多糖(SLRP)家族的降解增加,它调节胶原纤维的直径、强度和组装,并结合和修改结缔组织内修复性生长因子和降解性细胞因子的作用。在异常的椎间盘、软骨和肌腱中发现了SLRP和SLRP片段的合成改变。然而,关于这些片段是如何在这些组织中产生的,以及它们如何影响生长因子结合或胶原纤维的形成,人们知之甚少。这一不足将在我们拟议的研究中得到解决,该研究将为软骨、椎间盘和肌腱退变的机制提供新的信息,并可能在未来这些肌肉骨骼疾病的治疗研究中开发潜在的治疗和诊断靶点。
英文摘要
Back problems (M$700), OA (M$600), muscle and tendon disorders (M$500) accounted for 60% of musculoskeletal (MSK) health care expenditure in Australia in 1993-1994, were the second most common cause of presentations to a general practitioner, the third leading contributor to health system expenditure (>$3 billion) and accounted for ~300,000 hospital admissions, ~15 million medical services and over 13 million prescriptions. Significant disability due to MSK disease were noted in ~50% of people aged 65 years. Australian census data indicates that ageing trends will result in an increased incidence of MSK conditions as the longevity of the Australian population rises, exerting an ever increasing burden on the healthcare budget. Extreme levels of sporting or physical activity from traumatic loading of joints can lead to excessive loading of collagen fibres in MSK tissues leading to their failure and loss of tissue function. Common end stages of collagen fibre breakdown are preceded by matrix changes which may predispose MSK tissues to enzymatic and mechanical damage. One such change is an increased degradation of a family of small leucine-rich proteoglycans (SLRPs) which modulate the diameter, strength and assembly of collagen fibrils and bind and modify the effects of reparative growth factors and degradative cytokines within connective tissues. Altered synthesis of SLRPs and SLRP fragments have been identified in abnormal intervertebral disc, cartilage and tendon. Very little is known however about how these fragments are generated within these tissues and how they affect growth factor binding or collagen fibril formation. This deficiency will be addressed in our proposed study which will provide novel information on mechanisms of cartilage, intervertebral disc and tendon degeneration and potential therapeutic and diagnostic targets which may be exploited in future studies on the treatment of these musculoskeletal conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mesenchymal Progenitor cells and intervertebral disc repair
  • 批准号:
    nhmrc : 1004032
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $50.29万
  • 财政年份:
    2011
  • 负责人:
    Dr James Melrose
  • 依托单位:
Stem cell treatment for tendon degeneration
  • 批准号:
    nhmrc : 570922
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $45.69万
  • 财政年份:
    2009
  • 负责人:
    Dr James Melrose
  • 依托单位:
Proteoglycan metabolism in tendon degeneration
  • 批准号:
    nhmrc : 402626
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $31.28万
  • 财政年份:
    2006
  • 负责人:
    Dr James Melrose
  • 依托单位:
INVESTIGATIONS ON THE REGULATION OF INTERVERTEBRAL DISC CELL MATRIX METALLOPROTEINASES
  • 批准号:
    nhmrc : 211266
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $22.09万
  • 财政年份:
    2002
  • 负责人:
    Dr James Melrose
  • 依托单位:
国内基金
海外基金
昼夜节律性small RNA在血斑形成时间推断中的法医学应用研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
  • 批准号:
    82372015
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    熊丽琴
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
tRNA-derived small RNA上调YBX1/CCL5通路参与硼替佐米诱导慢性疼痛的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    张祥忠
  • 依托单位: